News

Which paclitaxel schedule works best for breast cancer?


 

AT THE ASCO ANNUAL MEETING 2013

CHICAGO – Dr. G. T. Budd, of the Cleveland Clinic, discusses the efficacy, side effects, and costs of giving paclitaxel weekly vs. every 2 weeks when treating breast cancer. Dr. Budd discussed trial results comparing the schedules in an interview at the annual meeting of the American Society of Clinical Oncology.

Recommended Reading

Supreme Court ponders patenting of human genes
MDedge ObGyn
Smaller margins too close for comfort in breast cancer
MDedge ObGyn
Online cancer community colaunched by ex-Google executive
MDedge ObGyn
Genetic tests gauge breast-cancer recurrence risk
MDedge ObGyn
Cancer-cell reprogramming poses new treatment challenge
MDedge ObGyn
Intratumor heterogeneity drives need for multiple biopsies
MDedge ObGyn
New imaging promises improved breast cancer utility
MDedge ObGyn
ASCO guidelines for fertility preservation affirm oocyte preservation
MDedge ObGyn
10 years of tamoxifen halves risk of death from breast cancer
MDedge ObGyn
How I screen patients at increased risk for breast cancer
MDedge ObGyn